LNTH News and Press, Lantheus Holdings Inc. From 06/30/19

Value investing is simple in concept, but not easy to do in real life. In a nutshell, value investing is about buying stocks for prices below the intrinsic value of the business. The idea is quite powerful and easy to understand, but finding undervalued stocks is much easier said than done. ...

Findings Show Improved Clinical Management and Decreased Length of Stay in Intensive Care Unit Patients Receiving DEFINITY-Enhanced Echocardiography Versus Non-Contrast Echocardiography Patients Lantheus Holdings, Inc. (NASDAQ: LNTH), the parent company of Lantheus Medical Imagi...

Company will also host a scientific symposium and interactive panel discussion focused on enhanced echocardiography Lantheus Holdings, Inc. (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture a...

Lantheus Holdings (NASDAQ: LNTH ) inks an agreement with privately held NanoMab Technology Limited to develop next-generation radiopharmaceuticals to use in immuno-oncology (I-O) therapies. More news on: Lantheus Holdings, Inc., Healthcare stocks news, Read more ...

Lantheus expands into immuno-oncology and pharmaceutical services business through the license of NanoMab’s NM-01, an anti-PD-L1 imaging biomarker, designed to evaluate tumor immune activity and potentially guide future patient selection for immuno-oncology treatment Lantheus...

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced th...

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced th...

Lantheus Holdings (LNTH) Q1 2019 Earnings Conference Call April 30, 2019, 08:00 ET Company Participants Mark Kinarney - Director, Investor Relations Mary Anne Heino - President & CEO Robert Marshall - CFO & Treasurer Conference Call Participants Raj Denhoy - Jefferi...

Lantheus (NASDAQ: LNTH ): Q1 Non-GAAP EPS of $0.28 beats by $0.03 ; GAAP EPS of $0.25. More news on: Lantheus Holdings, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Worldwide revenues of $86.5 million for the first quarter 2019, representing an increase of 4.7% over the prior year period Net income of $9.9 million for the first quarter 2019, representing an increase of 21.2% over the prior year period GAAP diluted EPS of $0.25 for the fir...